Vaccine Adjuvants Market

An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.

Vaccine Adjuvants Market contains market size and forecasts of Vaccine Adjuvants in global, including the following market information:

Global Vaccine Adjuvants Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Vaccine Adjuvants Market Sales, 2017-2022, 2023-2028, (MT)

Global top five Vaccine Adjuvants companies in 2021 (%)

The global Vaccine Adjuvants market was valued at 877.5 million in 2021 and is projected to reach US$ 1564.6 million by 2028, at a CAGR of 8.6% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Aluminum Adjuvant Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Vaccine Adjuvants include GSK, CSL Limited, Croda, SEPPIC, Novavax, SPI Pharma, Phibro, SDA BIO and Invivogen, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Vaccine Adjuvants manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Vaccine Adjuvants Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)

Global Vaccine Adjuvants Market Segment Percentages, by Type, 2021 (%)

Aluminum Adjuvant

Emulsions Adjuvant

Others

Global Vaccine Adjuvants Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)

Global Vaccine Adjuvants Market Segment Percentages, by Application, 2021 (%)

Human Vaccine

Veterinary Vaccine

Global Vaccine Adjuvants Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)

Global Vaccine Adjuvants Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Vaccine Adjuvants revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Vaccine Adjuvants revenues share in global market, 2021 (%)

Key companies Vaccine Adjuvants sales in global market, 2017-2022 (Estimated), (MT)

Key companies Vaccine Adjuvants sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

GSK

CSL Limited

Croda

SEPPIC

Novavax

SPI Pharma

Phibro

SDA BIO

Invivogen

Tj Kaiwei

OZ Biosciences

Brenntag Biosector

MVP Laboratories

Zhuoyue

Aphios